Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

US Centers for Disease Control reported three confirmed cases of people with haemophilia who had developed AIDS.

  • Read more about US Centers for Disease Control reported three confirmed cases of people with haemophilia who had developed AIDS.

Glasgow symposium considered liver disease in haemophilia.

  • Read more about Glasgow symposium considered liver disease in haemophilia.

Dr Craske reported to the UK Haemophilia Centre Directors ("UKHCDO") hepatitis outbreak in Bournemouth linked to commercial Factor 8.

  • Read more about Dr Craske reported to the UK Haemophilia Centre Directors ("UKHCDO") hepatitis outbreak in Bournemouth linked to commercial Factor 8.

First formal meeting of haemophilia centre directors took place.

  • Read more about First formal meeting of haemophilia centre directors took place.

PFC issued Z8, the equivalent of 8Y free from hepatitis as well as HIV.

  • Read more about PFC issued Z8, the equivalent of 8Y free from hepatitis as well as HIV.

Armour withdrew heat-treated Factorate following seroconversions.

  • Read more about Armour withdrew heat-treated Factorate following seroconversions.

BPL and PFL heat-treated F9 became routinely available.

  • Read more about BPL and PFL heat-treated F9 became routinely available.

Only 8Y was issued after this date.

  • Read more about Only 8Y was issued after this date.

All Factor 8 issued by BPL heat-treated by this date.

  • Read more about All Factor 8 issued by BPL heat-treated by this date.

BPL released first batches of 8Y for clinical trial.

  • Read more about BPL released first batches of 8Y for clinical trial.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 807
  • Page 808
  • Page 809
  • Page 810
  • Current page 811
  • Page 812
  • Page 813
  • Page 814
  • Page 815
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.